Opaganib 'completely inhibited' replication of the SARS-CoV-2 virus in in-vitro model of human bronchial tissue, Israeli firm says; study still to be submitted for peer review

Compassionate and experimental use of Opaganib in Israel has had 'encouraging results'; by inhibiting enzyme, drug helps reduce inflammation levels and halts virus from replicating

Pair treated with Opaganib, from biopharmaceutical firm RedHill, showed progress within a few days of starting treatment, company says